Skip to main content

Vyvgart Hytrulo efgartigimod alfa 1,008 mg and hyaluronidase 11,200 units per 5.6 mL (180 mg/2,000 units per mL) single-dose vial Images

Generic Name: efgartigimod alfa/hyaluronidase

This medication has been identified as Vyvgart Hytrulo efgartigimod alfa 1,008 mg and hyaluronidase 11,200 units per 5.6 mL (180 mg/2,000 units per mL) single-dose vial and is used for Chronic Inflammatory Demyelinating Polyradiculoneuropathy, and Myasthenia Gravis. It belongs to the drug class immune globulins and is not a controlled substance.

Images of medication

Vyvgart hytrulo efgartigimod alfa 1,008 mg and hyaluronidase 11,200 units per 5.6 mL (180 mg/2,000 units per mL) single-dose vial medicine

Vyvgart Hytrulo

Generic Name
efgartigimod alfa/hyaluronidase
Strength
efgartigimod alfa 1,008 mg and hyaluronidase 11,200 units per 5.6 mL (180 mg/2,000 units per mL) single-dose vial
Availability
Prescription only
Drug Class
Immune globulins
CSA Schedule
Not a controlled drug
Labeler / Supplier
argenx US, Inc.
Manufacturer
Halozyme Therapeutics, Inc.
National Drug Code (NDC)
73475-3102

Get help with Imprint Code FAQs.

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.